{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:42:00Z","timestamp":1789994520742,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Heilongjiang Provincial Department of health","award":["2011-032"],"award-info":[{"award-number":["2011-032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40246-018-0184-0","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T13:55:47Z","timestamp":1543931747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction"],"prefix":"10.1186","volume":"12","author":[{"given":"Jiantao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiemei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"issue":"1","key":"184_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Arnlov J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Barnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castaneda-Orjuela CA, Castillo-Rivas J, Catala-Lopez F, Choi JY, Christensen H, Cirillo M, Cooper L Jr, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi M, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabares-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M, Murray C. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"issue":"21","key":"184_CR3","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"JL Anderson","year":"2017","unstructured":"Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053\u201364.","journal-title":"N Engl J Med"},{"issue":"9","key":"184_CR4","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.7150\/thno.22878","volume":"8","author":"J Yuan","year":"2018","unstructured":"Yuan J, Liu H, Gao W, Zhang L, Ye Y, Yuan L, Ding Z, Wu J, Kang L, Zhang X, Wang X, Zhang G, Gong H, Sun A, Yang X, Chen R, Cui Z, Ge J, Zou Y. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress. Theranostics. 2018;8(9):2565\u201382.","journal-title":"Theranostics"},{"issue":"5","key":"184_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00395-015-0504-7","volume":"110","author":"GP Diniz","year":"2015","unstructured":"Diniz GP, Lino CA, Guedes EC, Moreira Ldo N, Barreto-Chaves ML. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via type 1 angiotensin II receptor. Basic Res Cardiol. 2015;110(5):49.","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"184_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/FJC.0000000000000203","volume":"65","author":"L Wei","year":"2015","unstructured":"Wei L, Yuan M, Zhou R, Bai Q, Zhang W, Zhang M, Huang Y, Shi L. MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a. J Cardiovasc Pharmacol. 2015;65(4):357\u201363.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"184_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2009.11.005","volume":"391","author":"J Ai","year":"2010","unstructured":"Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010;391(1):73\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"184_CR8","first-page":"303","volume":"7","author":"L Zhang","year":"2015","unstructured":"Zhang L, Chen X, Su T, Li H, Huang Q, Wu D, Yang C, Han Z. Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J Thorac Dis. 2015;7(3):303\u20138.","journal-title":"J Thorac Dis"},{"issue":"2","key":"184_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1536\/ihj.15-293","volume":"57","author":"X Yang","year":"2016","unstructured":"Yang X, Qin Y, Shao S, Yu Y, Zhang C, Dong H, Lv G, Dong S. MicroRNA-214 inhibits left ventricular remodeling in an acute myocardial infarction rat model by suppressing cellular apoptosis via the phosphatase and Tensin homolog (PTEN). Int Heart J. 2016;57(2):247\u201350.","journal-title":"Int Heart J"},{"key":"184_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fcvm.2018.00073","volume":"5","author":"A Das","year":"2018","unstructured":"Das A, Samidurai A, Salloum FN. Deciphering non-coding RNAs in cardiovascular health and disease. Front Cardiovasc Med. 2018;5:73.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"184_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbrc.2012.10.040","volume":"428","author":"MH Jeong","year":"2012","unstructured":"Jeong MH, Lee JS, Kim DH, Park WJ, Yang DK. Identification of novel microRNAs negatively regulating cardiac hypertrophy. Biochem Biophys Res Commun. 2012;428(1):191\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"184_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.yjmcc.2012.04.012","volume":"53","author":"KC Yang","year":"2012","unstructured":"Yang KC, Ku YC, Lovett M, Nerbonne JM. Combined deep microRNA and mRNA sequencing identifies protective transcriptomal signature of enhanced PI3Kalpha signaling in cardiac hypertrophy. J Mol Cell Cardiol. 2012;53(1):101\u201312.","journal-title":"J Mol Cell Cardiol"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3389\/fphys.2016.00565","volume":"7","author":"ET Santana","year":"2016","unstructured":"Santana ET, Feliciano RD, Serra AJ, Brigidio E, Antonio EL, Tucci PJ, Nathanson L, Morris M, Silva JA Jr. Comparative mRNA and MicroRNA profiling during acute myocardial infarction induced by coronary occlusion and ablation radio-frequency currents. Front Physiol. 2016;7:565.","journal-title":"Front Physiol"},{"issue":"8","key":"184_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"184_CR15","doi-asserted-by":"crossref","unstructured":"Donner Y, Kazmierczak S, Fortney K. Drug repurposing using deep embeddings of gene expression profiles. Mol Pharm. 2018.","DOI":"10.1021\/acs.molpharmaceut.8b00284"},{"key":"184_CR16","doi-asserted-by":"crossref","unstructured":"Athauda D, Foltynie T. Drug repurposing in Parkinson\u2019s disease. CNS Drugs. 2018.","DOI":"10.1007\/s40263-018-0548-y"},{"issue":"1","key":"184_CR17","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1038\/s41598-018-26411-7","volume":"8","author":"A Datta","year":"2018","unstructured":"Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, Southall N, Hu X, Lal M, Mondal D, Ferrer M, Abdel-Mageed AB. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer. Sci Rep. 2018;8(1):8161.","journal-title":"Sci Rep"},{"issue":"21","key":"184_CR18","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1073\/pnas.200327197","volume":"97","author":"LA Amaral","year":"2000","unstructured":"Amaral LA, Scala A, Barthelemy M, Stanley HE. Classes of small-world networks. Proc Natl Acad Sci U S A. 2000;97(21):11149\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"184_CR19","doi-asserted-by":"crossref","first-page":"41737","DOI":"10.18632\/oncotarget.9569","volume":"7","author":"Y Cao","year":"2016","unstructured":"Cao Y, Wang P, Ning S, Xiao W, Xiao B, Li X. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Oncotarget. 2016;7(27):41737\u201347.","journal-title":"Oncotarget"},{"issue":"1","key":"184_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1109\/JBHI.2014.2344732","volume":"19","author":"T Simos","year":"2015","unstructured":"Simos T, Georgopoulou U, Thyphronitis G, Koskinas J, Papaloukas C. Analysis of protein interaction networks for the detection of candidate hepatitis B and C biomarkers. IEEE J Biomed Health Inform. 2015;19(1):181\u20139.","journal-title":"IEEE J Biomed Health Inform"},{"issue":"7134","key":"184_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05602","volume":"446","author":"M Sano","year":"2007","unstructured":"Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446(7134):444\u20138.","journal-title":"Nature"},{"issue":"6","key":"184_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCRESAHA.107.163428","volume":"102","author":"HJ Evans-Anderson","year":"2008","unstructured":"Evans-Anderson HJ, Alfieri CM, Yutzey KE. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ Res. 2008;102(6):686\u201394.","journal-title":"Circ Res"},{"issue":"11","key":"184_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","volume":"114","author":"YG Ni","year":"2006","unstructured":"Ni YG, Berenji K, Wang N, Oh M, Sachan N, Dey A, Cheng J, Lu G, Morris DJ, Castrillon DH, Gerard RD, Rothermel BA, Hill JA. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation. 2006;114(11):1159\u201368.","journal-title":"Circulation"},{"issue":"6","key":"184_CR24","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1074\/jbc.M310405200","volume":"279","author":"JR McMullen","year":"2004","unstructured":"McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem. 2004;279(6):4782\u201393.","journal-title":"J Biol Chem"},{"issue":"5","key":"184_CR25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1128\/MCB.01110-06","volume":"27","author":"PG Laustsen","year":"2007","unstructured":"Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao R, Kahn CR. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol. 2007;27(5):1649\u201364.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"184_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","volume":"35","author":"H Nakagami","year":"2003","unstructured":"Nakagami H, Takemoto M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol. 2003;35(7):851\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"16","key":"184_CR27","doi-asserted-by":"publisher","first-page":"12913","DOI":"10.1074\/jbc.M111.331751","volume":"287","author":"I Knezevic","year":"2012","unstructured":"Knezevic I, Patel A, Sundaresan NR, Gupta MP, Solaro RJ, Nagalingam RS, Gupta M. A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival. J Biol Chem. 2012;287(16):12913\u201326.","journal-title":"J Biol Chem"},{"issue":"5","key":"184_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/17425255.2018.1472237","volume":"14","author":"M Nakano","year":"2018","unstructured":"Nakano M, Nakajima M. Current knowledge of microRNA-mediated regulation of drug metabolism in humans. Expert Opin Drug Metab Toxicol. 2018;14(5):493\u2013504.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.omtn.2017.12.002","volume":"10","author":"T Zhan","year":"2018","unstructured":"Zhan T, Huang X, Tian X, Chen X, Ding Y, Luo H, Zhang Y. Downregulation of MicroRNA-455-3p links to proliferation and drug resistance of pancreatic cancer cells via targeting TAZ. Mol Ther Nucleic Acids. 2018;10:215\u201326.","journal-title":"Mol Ther Nucleic Acids"},{"key":"184_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphar.2017.00003","volume":"8","author":"M Lopez-Riera","year":"2017","unstructured":"Lopez-Riera M, Conde I, Tolosa L, Zaragoza A, Castell JV, Gomez-Lechon MJ, Jover R. New microRNA biomarkers for drug-induced steatosis and their potential to predict the contribution of drugs to non-alcoholic fatty liver disease. Front Pharmacol. 2017;8:3.","journal-title":"Front Pharmacol"},{"issue":"9","key":"184_CR31","doi-asserted-by":"publisher","first-page":"e108051","DOI":"10.1371\/journal.pone.0108051","volume":"9","author":"Praful Aggarwal","year":"2014","unstructured":"Aggarwal, P.; Turner, A.; Matter, A.; Kattman, S. J.; Stoddard, A.; Lorier, R.; Swanson, B. J.; Arnett, D. K.; Broeckel, U., RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model. PLoS One 2014, 9, (9), e108051.","journal-title":"PLoS ONE"},{"issue":"D1","key":"184_CR32","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pinero","year":"2017","unstructured":"Pinero J, Bravo A, Queralt-Rosinach N, Gutierrez-Sacristan A, Deu-Pons J, Centeno E, Garcia-Garcia J, Sanz F, Furlong LI. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45(D1):D833\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"184_CR33","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, Chiew MY, Tai CS, Wei TY, Tsai TR, Huang HT, Wang CY, Wu HY, Ho SY, Chen PR, Chuang CH, Hsieh PJ, Wu YS, Chen WL, Li MJ, Wu YC, Huang XY, Ng FL, Buddhakosai W, Huang PC, Lan KC, Huang CY, Weng SL, Cheng YN, Liang C, Hsu WL, Huang HD. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296\u2013302.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"184_CR34","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"184_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nbt1203","volume":"24","author":"S Aerts","year":"2006","unstructured":"Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan B, Carmeliet P, Moreau Y. Gene prioritization through genomic data fusion. Nat Biotechnol. 2006;24(5):537\u201344.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"184_CR36","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3.","journal-title":"Genome Biol"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-018-0184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40246-018-0184-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-018-0184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T18:49:17Z","timestamp":1605552557000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-018-0184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1186\/s40246-018-0184-0","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"52"}}